SDS & Science Snapshots (2022-05-08)
In this issue: Dr. Bezzerri provides an update on a therapeutic approach targeting premature termination codon (PTC) mutations in SDS, or...
Every successful therapy is a result of a tried-and-true strategy: support researchers, recruit specific expertise, and coordinate research. Our mission is to replicate the success for SDS. Will you join us?
Your donation will be used exclusively for SDS research. Our management team is not taking any salary; all operating costs are covered by a separate account, supported by donors whom we approach privately.